INS and type 2 diabetes mellitus: Wada et al.28 examined individuals with non-insulin-treated T2D with baseline HbA1c of 7.8%; the researchers did not measure lifestyle changes, but showed that use of flash CGM as compared to SMBG resulted in a reduction in HbA1c at 24 weeks (0.29%, p = 0.02).